Woods Keith — SEC insider filings

SEC reporting owner CIK 1996804. 19 insider filings on record with FilingPulse; latest filed 2026-09-25.

Transaction summary — filings shown

Covers all 19 filings on record, filed 2023-10-18 to 2026-09-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Scholar Rock Holding Corp (SRRK)Chief Operating Officer6—2 legs · 26,966 sh · $1,221,7065
Neurogene Inc. (NGNE)Director4——4
TScan Therapeutics, Inc. (TCRX)Director4——4
ROCKET PHARMACEUTICALS, INC. (RCKT)Director2——3
X4 Pharmaceuticals, Inc (XFOR)Director3——3

Insider filings — Woods Keith

FiledFormIssuerReported transactionsSource
2026-09-254Scholar Rock Holding Corp (SRRK)Gift (G): 48,034 @ $0EDGAR
2026-06-164/ANeurogene Inc. (NGNE)Grant/award (A): 12,050 (derivative) @ $0EDGAR
2026-06-164/ANeurogene Inc. (NGNE)Grant/award (A): 7,700 (derivative) @ $0EDGAR
2026-06-164/ANeurogene Inc. (NGNE)Grant/award (A): 15,400 (derivative) @ $0EDGAR
2026-05-224TScan Therapeutics, Inc. (TCRX)Grant/award (A): 67,000 (derivative) @ $0EDGAR
2026-04-204Scholar Rock Holding Corp (SRRK)Sale (S): 10,220 @ $49.57EDGAR
2026-02-244Neurogene Inc. (NGNE)Grant/award (A): 12,050 (derivative) @ $0EDGAR
2026-02-114Scholar Rock Holding Corp (SRRK)Grant/award (A): 47,021 @ $0EDGAR
2026-01-154Scholar Rock Holding Corp (SRRK)Sale (S): 16,746 @ $42.70EDGAR
2025-07-024TScan Therapeutics, Inc. (TCRX)Grant/award (A): 67,000 (derivative) @ $0EDGAR
2025-06-104X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 1,500 @ $0EDGAR
2025-05-064Scholar Rock Holding Corp (SRRK)Grant/award (A): 110,067 (derivative) @ $0EDGAR
2025-04-294Scholar Rock Holding Corp (SRRK)Grant/award (A): 100,000 @ $0 · Grant/award (A): 500,000 @ $0EDGAR
2024-06-204ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 23,944 (derivative) @ $0EDGAR
2024-06-144TScan Therapeutics, Inc. (TCRX)Grant/award (A): 47,500 (derivative) @ $0EDGAR
2024-06-114X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 45,000 @ $0EDGAR
2023-12-124ROCKET PHARMACEUTICALS, INC. (RCKT)Grant/award (A): 20,522 (derivative) @ $0 · Grant/award (A): 11,960 (derivative) @ $0EDGAR
2023-12-084TScan Therapeutics, Inc. (TCRX)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-10-184X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 90,000 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1996804 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs